RHEUPP - A Rheumatological Follow-up Management App - Trial NCT06217172
Access comprehensive clinical trial information for NCT06217172 through Pure Global AI's free database. This phase not specified trial is sponsored by Hospital de Clinicas de Porto Alegre and is currently Not yet recruiting. The study focuses on Rheumatoid Arthritis. Target enrollment is 88 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Hospital de Clinicas de Porto Alegre
Timeline & Enrollment
N/A
Jan 01, 2024
Dec 01, 2025
Primary Outcome
Non-inferiority of telehealth monitoring according to differences in means of CDAI
Summary
The purpose of this Non-inferiority Randomized Clinical Trial is to evaluate the
 effectiveness of RHEUPP App during telehealth follow-up in a population of Rheumatoid
 Arthritis patients from a Tertiary Rheumatology Service in South Brazil.
 
 The main question[s] it aims to answer are:
 
 • Using RHEUPP App in telemedicine is not inferior to usual care in terms of means obtained
 by CDAI.
 
 Participants will be stratified by CDAI and then randomized 1:1 for intervention or control
 group. They will be evaluated at study starting, in 3 and 6 months, an extended evaluation
 after 12 months of recruitment is predicted.
 
 Researchers will compare intervention and control group to detect differences between usual
 care and Telehealth follow-up and determine if the last is not less effective in our study
 population of rheumatic patients.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06217172
Device Trial